Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Ema Paulovičová, Lucia Paulovičová, Alžbeta Čížová, Jana Mečárová, Romana Vrzoňová, Pavol Farkaš & Slavomír Bystrický. (2023) Amphoteric Mannan as an Immune Response Modifier. New Model Immunobiologically Active Candida albicans Mannan-Based Formula. Immunological Investigations 52:4, pages 415-438.
Read now
Read now
Henderson Zhu, Christine S. Rollier & Andrew J. Pollard. (2021) Recent advances in lipopolysaccharide-based glycoconjugate vaccines. Expert Review of Vaccines 20:12, pages 1515-1538.
Read now
Read now
Jan Dolhain, Winnie Janssens, Vasundhara Dindore & Attila Mihalyi. (2020) Infant vaccine co-administration: review of 18 years of experience with GSK’s hexavalent vaccine co-administered with routine childhood vaccines. Expert Review of Vaccines 19:5, pages 419-443.
Read now
Read now
Shuchen Wang, Monica Tafalla, Linda Hanssens & Jan Dolhain. (2017) A review of Haemophilus influenzae disease in Europe from 2000–2014: challenges, successes and the contribution of hexavalent combination vaccines. Expert Review of Vaccines 16:11, pages 1095-1105.
Read now
Read now
H Findlow & R Borrow. (2016) Interactions of conjugate vaccines and co-administered vaccines. Human Vaccines & Immunotherapeutics 12:1, pages 226-230.
Read now
Read now
Jan T Poolman, Carla CAM Peeters & Germie PJM van den Dobbelsteen. (2013) The history of pneumococcal conjugate vaccine development: dose selection. Expert Review of Vaccines 12:12, pages 1379-1394.
Read now
Read now
Marta C Nunes & Shabir A Madhi. (2013) Review of a new fully liquid, hexavalent vaccine: Hexaxim
. Expert Opinion on Biological Therapy 13:4, pages 575-593.
Read now
Read now
Beatriz Quiambao, Olivier Van Der Meeren, Devayani Kolhe & Salvacion Gatchalian. (2012) A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus- type b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers. Human Vaccines & Immunotherapeutics 8:3, pages 347-354.
Read now
Read now
Guillermo M. Ruiz-Palacios, M. Lourdes Guerrero, Lorena Hernández-Delgado, Antonio Lavalle-Villalobos, Abigail Casas-Muñoz, Yolanda Cervantes-Apolinar, Marta Moreira & Lode Schuerman. (2011) Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants. Human Vaccines 7:11, pages 1137-1145.
Read now
Read now
Ray Borrow, Ron Dagan, Fred Zepp, Hans Hallander & Jan Poolman. (2011) Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules. Expert Review of Vaccines 10:11, pages 1621-1631.
Read now
Read now
Roman Prymula & Lode Schuerman. (2009) 10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix™. Expert Review of Vaccines 8:11, pages 1479-1500.
Read now
Read now
Fred Zepp, Heinz-Josef Schmitt, Jan Cleerbout, Thomas Verstraeten, Lode Schuerman & Jeanne-Marie Jacquet. (2009) Review of 8 years of experience with Infanrix hexa™ (DTPa–HBV–IPV/Hib hexavalent vaccine). Expert Review of Vaccines 8:6, pages 663-678.
Read now
Read now
Ray Borrow & Jamie Findlow. (2009) Prevention of meningococcal serogroup C disease by NeisVac-C™. Expert Review of Vaccines 8:3, pages 265-279.
Read now
Read now
Articles from other publishers (43)
Mario U. Mondelli. (2023) Does co-administration of vaccines interfere with immune responses? The jury is still out. Clinical Microbiology and Infection 29:12, pages 1482-1484.
Crossref
Crossref
Yiwen Xie, Xuebin Tian, Xiaodi Zhang, Hangping Yao & Nanping Wu. (2023) Immune interference in effectiveness of influenza and COVID-19 vaccination. Frontiers in Immunology 14.
Crossref
Crossref
Keith P. Klugman, Richard Malley & Cynthia G. Whitney. 2023. Plotkin's Vaccines. Plotkin's Vaccines
826
868.e18
.
M. P. E. Slack, A. W. Cripps, K. Grimwood, G. A. Mackenzie & M. Ulanova. (2021) Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use. Clinical Microbiology Reviews 34:3.
Crossref
Crossref
Mary P. E. Slack. 2021. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
195
206
.
Mohamed Tashani, Al-Mamoon Badahdah, Mohammad Alfelali, Osamah Barasheed, Amani S. Alqahtani, Leon Heron, Melanie Wong, Jennifer Louth, Harunor Rashid, Ray Borrow & Robert Booy. (2019) Effect on meningococcal serogroup W immunogenicity when Tdap was administered prior, concurrent or subsequent to the quadrivalent (ACWY) meningococcal CRM197-conjugate vaccine in adult Hajj pilgrims: A randomised controlled trial. Vaccine 37:27, pages 3562-3567.
Crossref
Crossref
N. Dumpa, K. Goel, Yuhan Guo, H. McFall, Amit Raviraj Pillai, Ashay Shukla, M. A. Repka & S. Narasimha Murthy. (2019) Stability of Vaccines. AAPS PharmSciTech 20:2.
Crossref
Crossref
Nicholas Wood, Terry Nolan, Helen Marshall, Peter Richmond, Emma Gibbs, Kirsten Perrett & Peter McIntyre. (2018) Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth. JAMA Pediatrics 172:11, pages 1045.
Crossref
Crossref
Keith P. Klugman, Ron Dagan, Richard Malley & Cynthia G. Whitney. 2018. Plotkin's Vaccines. Plotkin's Vaccines
773
815.e18
.
Tyler D. Moeller, Kevin B. Weyant & Matthew P. DeLisa. 2021. Advances in Glycobiotechnology. Advances in Glycobiotechnology
355
378
.
Henry H. Bernstein & Elisabeth R. Seyferth. (2017) Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid. Vaccine 35:48, pages 6707-6711.
Crossref
Crossref
Mohamed Tashani, Leon Heron, Melanie Wong, Harunor Rashid & Robert Booy. (2017) Tetanus–diphtheria–pertussis vaccine may suppress the immune response to subsequent immunization with pneumococcal CRM197-conjugate vaccine (coadministered with quadrivalent meningococcal TT-conjugate vaccine): a randomized, controlled trial⋆. Journal of Travel Medicine 24:4.
Crossref
Crossref
Angela Huttner, Christoph Hatz, Germie van den Dobbelsteen, Darren Abbanat, Alena Hornacek, Rahel Frölich, Anita M Dreyer, Patricia Martin, Todd Davies, Kellen Fae, Ingrid van den Nieuwenhof, Stefan Thoelen, Serge de Vallière, Anette Kuhn, Enos Bernasconi, Volker Viereck, Tilemachos Kavvadias, Kerstin Kling, Gloria Ryu, Tanja Hülder, Sabine Gröger, David Scheiner, Cristina Alaimo, Stephan Harbarth, Jan Poolman & Veronica Gambillara Fonck. (2017) Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial. The Lancet Infectious Diseases 17:5, pages 528-537.
Crossref
Crossref
Mary P. E. Slack. 2017. Pediatric Vaccines and Vaccinations. Pediatric Vaccines and Vaccinations
171
181
.
M. Tashani, M. Alfelali, O. Barasheed, A.S. Alqahtani, L. Heron, M. Wong, H. Rashid & R. Booy. (2016) Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: A randomised controlled trial. Vaccine 34:48, pages 5929-5937.
Crossref
Crossref
Timothy Cardozo, Sergey V. Shmelkov, Kenneth Carr, John Rotrosen, Pedro Mateu-Gelabert & Samuel R. Friedman. 2016. Biologics to Treat Substance Use Disorders. Biologics to Treat Substance Use Disorders
75
103
.
Martin Alberer, Gerd Burchard, Tomas Jelinek, Emil C. Reisinger, Seetha Meyer, Eduardo Forleo‐Neto, Alemnew F. Dagnew & Ashwani Kumar Arora. (2015) Immunogenicity and Safety of Concomitant Administration of a Combined Hepatitis A/B Vaccine and a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults. Journal of Travel Medicine 22:2, pages 105-114.
Crossref
Crossref
Shamez N. Ladhani, Nick J. Andrews, Pauline Waight, Bassam Hallis, Mary Matheson, Anna England, Helen Findlow, Xilian Bai, Ray Borrow, Polly Burbidge, Emma Pearce, David Goldblatt & Elizabeth Miller. (2015) Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule. Vaccine 33:5, pages 648-655.
Crossref
Crossref
Stephanie A. Jones, Michelle Groome, Anthonet Koen, Nadia Van Niekerk, Poonam Sewraj, Locadiah Kuwanda, Alane Izu, Peter V. Adrian & Shabir A. Madhi. (2013) Immunogenicity of Seven-Valent Pneumococcal Conjugate Vaccine Administered at 6, 14 and 40 Weeks of Age in South African Infants. PLoS ONE 8:8, pages e72794.
Crossref
Crossref
Keith P. Klugman, Steven Black, Ron Dagan, Richard Malley & Cynthia G. Whitney. 2013. Vaccines. Vaccines
504
541
.
S. I. Romaniuk, D. V. Kolybo & S. V. Komisarenko. (2012) Recombinant diphtheria toxin derivatives: Perspectives of application. Russian Journal of Bioorganic Chemistry 38:6, pages 565-577.
Crossref
Crossref
Shamez N. Ladhani. (2012) Two Decades of Experience With the Haemophilus influenzae Serotype b Conjugate Vaccine in the United Kingdom. Clinical Therapeutics 34:2, pages 385-399.
Crossref
Crossref
Nobuhiro NORO. (2012) S1-2. Progress of Regulatory Science --Biological Products--. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 43:3, pages 171-172.
Crossref
Crossref
Chang-Hwi Kim, Jung Soo Kim, Sung-Ho Cha, Kwang-Nam Kim, Jong-Duck Kim, Kyung Yil Lee, Hwang Min Kim, Jong-Hyun Kim, Sang Hyuk, Jung-Yun Hong, Su Eun Park, Yun-Kyung Kim, Nam Hee Kim, Aurélie Fanic, Dorota Borys, Javier Ruiz-Guiñazù, Marta Moreira, Lode Schuerman & Kyung-Hyo Kim. (2011) Response to Primary and Booster Vaccination With 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine in Korean Infants. Pediatric Infectious Disease Journal 30:12, pages e235-e243.
Crossref
Crossref
Menno R. van den Bergh, Judith Spijkerman, Nancy François, Kristien Swinnen, Dorota Borys, Lode Schuerman, Reinier H. Veenhoven & Elisabeth A. M. Sanders. (2011) Immunogenicity, Safety, and Reactogenicity of the 10-valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine and DTPa-IPV-Hib When Coadministered as a 3-dose Primary Vaccination Schedule in the Netherlands. Pediatric Infectious Disease Journal 30:9, pages e170-e178.
Crossref
Crossref
Anita H.J. van den Biggelaar, William Pomat, Anthony Bosco, Suparat Phuanukoonnon, Catherine J. Devitt, Marie A. Nadal-Sims, Peter M. Siba, Peter C. Richmond, Deborah Lehmann & Patrick G. Holt. (2011) Pneumococcal conjugate vaccination at birth in a high-risk setting: No evidence for neonatal T-cell tolerance. Vaccine 29:33, pages 5414-5420.
Crossref
Crossref
Markus Knuf, Frank Kowalzik & Dorothee Kieninger. (2011) Comparative effects of carrier proteins on vaccine-induced immune response. Vaccine 29:31, pages 4881-4890.
Crossref
Crossref
Nicholas Wood & Claire-Anne Siegrist. (2011) Neonatal immunization: where do we stand?. Current Opinion in Infectious Diseases 24:3, pages 190-195.
Crossref
Crossref
Ping Wang, Yunhui Liu, Xiuli Shang & Yixue Xue. (2010) CRM197-Induced Blood–Brain Barrier Permeability Increase is Mediated by Upregulation of Caveolin-1 Protein. Journal of Molecular Neuroscience 43:3, pages 485-492.
Crossref
Crossref
S. Ladhani, R. Borrow & M. E. Ramsay. (2011) Commentary on ‘Combined DTP‐HBV‐HIB vaccine versus separately administered DTP‐HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)’. Evidence-Based Child Health: A Cochrane Review Journal 6:1, pages 68-70.
Crossref
Crossref
Ron Dagan, Jan Poolman & Claire-Anne Siegrist. (2010) Glycoconjugate vaccines and immune interference: A review. Vaccine 28:34, pages 5513-5523.
Crossref
Crossref
Timo Vesikari, Aino Karvonen, Niklas Lindblad, Tiina Korhonen, Patricia Lommel, Paul Willems, Ilse Dieussaert & Lode Schuerman. (2010) Safety and Immunogenicity of a Booster Dose of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine Coadministered With Measles-Mumps-Rubella-Varicella Vaccine in Children Aged 12 to 16 Months. Pediatric Infectious Disease Journal 29:6, pages e47-e56.
Crossref
Crossref
Olivia J. White, Julie Rowe, Peter Richmond, Helen Marshall, Peter McIntyre, Nicholas Wood & Patrick G. Holt. (2010) Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine 28:14, pages 2648-2652.
Crossref
Crossref
Colin D. Marchant, Jacqueline M. Miller, Gary S. Marshall, Mark Blatter, Emmanuel Aris, Leonard R. Friedland & Dominique Boutriau. (2010) Randomized Trial to Assess Immunogenicity and Safety of Haemophilus influenzae Type b and Neisseria meningitidis Serogroups C and Y–Tetanus Toxoid Conjugate Vaccine in Infants. Pediatric Infectious Disease Journal 29:1, pages 48-52.
Crossref
Crossref
Lode Schuerman, Dorota Borys, Bernard Hoet, Arne Forsgren & Roman Prymula. (2009) Prevention of otitis media: Now a reality?. Vaccine 27:42, pages 5748-5754.
Crossref
Crossref
Peter Paradiso. (2009) Essential criteria for evaluation of pneumococcal conjugate vaccine candidates. Vaccine 27, pages C15-C18.
Crossref
Crossref
Markus Knuf, Leszek Szenborn, Masnuel Moro, Christian Petit, Nancy Bermal, Laurence Bernard, Ilse Dieussaert & Lode Schuerman. (2009) Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV). Pediatric Infectious Disease Journal 28:4, pages S97-S108.
Crossref
Crossref
Ron Dagan & Carl Frasch. (2009) Introduction. Pediatric Infectious Disease Journal 28:4, pages S63-S65.
Crossref
Crossref
Rosanna Lagos, Alma Munoz, Myron M. Levine, Wendy Watson, Ih Chang & Peter Paradiso. (2009) Immunology of combining CRM197 conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants. Vaccine 27:17, pages 2299-2305.
Crossref
Crossref
Eva Maria Pöllabauer, Robert Petermann & Hartmut J. Ehrlich. (2009) The influence of carrier protein on the immunogenicity of simultaneously administered conjugate vaccines in infants. Vaccine 27:11, pages 1674-1679.
Crossref
Crossref
Dominic F. Kelly, E. Richard Moxon, Ly-Mee Yu & Andrew J. Pollard. (2009)
Anti-Polyribosylribitol Phosphate Antibody Concentrations and Avidities in Children since the Start of
Haemophilus influenzae
Type b Immunization of Infants in the United Kingdom
. Clinical and Vaccine Immunology 16:2, pages 246-252.
Crossref
Crossref
Elizabeth N. De Gaspari. (2008)
The Use of Monoclonal Antibodies to
Neisseria lactamica
in an Antigen Selection to
Neisseria meningitidis
B Vaccine
. Hybridoma 27:5, pages 387-393.
Crossref
Crossref
Claire-Anne Siegrist. (2008) Blame Vaccine Interference, Not Neonatal Immunization, for Suboptimal Responses after Neonatal Diphtheria, Tetanus, and Acellular Pertussis Immunization. The Journal of Pediatrics 153:3, pages 305-307.
Crossref
Crossref